The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Journal article
Zhou D. et al, (2024), Nature communications, 15
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Journal article
Michael BD. et al, (2023), Nature communications, 14
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Journal article
Roper KJ. et al, (2023), Scientific Reports, 13
Structural comparison of typical and atypical E2 pestivirus glycoproteins.
Journal article
Aitkenhead H. et al, (2023), Structure (London, England : 1993)
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
Journal article
Bou-Antoun S. et al, (2023), The Journal of antimicrobial chemotherapy, 78, ii37 - ii42
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Journal article
Bešević J. et al, (2023), Journal of epidemiology and community health
Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.
Journal article
El Omari K. et al, (2023), Commun Chem, 6
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.
Journal article
Ni T. et al, (2023), iScience, 26
Structure of Bovine CD46 Ectodomain
Journal article
Aitkenhead H. et al, (2023), Viruses, 15, 1424 - 1424
Accelerating drug target inhibitor discovery with a deep generative foundation model.
Journal article
Chenthamarakshan V. et al, (2023), Science advances, 9
Broadly neutralizing antibodies against COVID-19.
Journal article
Zhou D. et al, (2023), Current opinion in virology, 61
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.
Journal article
Ragonnet-Cronin M. et al, (2023), Nature communications, 14
Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer
Journal article
Pei X. et al, (2023), Nature Communications, 14
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
Preprint
Zhang P. et al, (2023)
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Journal article
Wei J. et al, (2023), Nature Communications, 14
Investigation of the milling characteristics of different focused-ion-beam sources assessed by three-dimensional electron diffraction from crystal lamellae.
Journal article
Parkhurst JM. et al, (2023), IUCrJ
Characterization of the rotavirus assembly pathway in situ using cryoelectron tomography
Journal article
Shah PNM. et al, (2023), Cell Host & Microbe, 31, 604 - 615.e4
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Journal article
Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271
Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2
Preprint
Stuart D. et al, (2023)
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Journal article
Siggins MK. et al, (2023), Immunology, 168, 473 - 492
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Journal article
Goldswain H. et al, (2023), Genome biology, 24
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
Journal article
Emmenegger M. et al, (2023), iScience, 26, 105928 - 105928
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Journal article
Huo J. et al, (2023), Cell Reports, 42, 111903 - 111903
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Journal article
Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402
Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.
Journal article
Bahar MW. et al, (2022), Commun Biol, 5
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.
Journal article
Bahar MW. et al, (2022), Commun Biol, 5
Switching of Receptor Binding Poses between Closely Related Enteroviruses
Journal article
Zhou D. et al, (2022), Viruses, 14, 2625 - 2625
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6.
Journal article
Dijokaite-Guraliuc A. et al, (2022), Cell discovery, 8
Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum.
Journal article
Huo J. et al, (2022), Cell discovery, 8
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study.
Journal article
Vink E. et al, (2022), Open forum infectious diseases, 9
Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris.
Journal article
Sherry L. et al, (2022), Viruses, 14
Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIX.
Journal article
Shirasaki T. et al, (2022), PLoS pathogens, 18
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Journal article
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
Delineating organizational principles of the endogenous L-A virus by cryo-EM and computational analysis of native cell extracts
Preprint
Schmidt L. et al, (2022)
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Journal article
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Journal article
Wei J. et al, (2022), Nature Communications, 13
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
Journal article
Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Journal article
Knight SR. et al, (2022), Thorax, 77, 606 - 615
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Preprint
Tuekprakhon A. et al, (2022)
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Journal article
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Journal article
Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Purification of African Swine Fever Virus.
Journal article
Shimmon GL. et al, (2022), Methods in molecular biology (Clifton, N.J.), 2503, 179 - 186
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Journal article
Huang K-YA. et al, (2022), Theranostics, 12, 1 - 17
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Journal article
Dejnirattisai W. et al, (2021), Lancet (London, England)
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Preprint
Dejnirattisai W. et al, (2021)
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Journal article
Halawa S. et al, (2021), Nature reviews. Cardiology
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Journal article
Tan TK. et al, (2021), Nature Communications, 12